Cutaneous metastasis from pancreatic cancer: A case report and systematic review of the literature

Zhou,Hai‑Yan; Wang,Xian‑Bao; Gao,Fang; Bu,Bing; Zhang,Shu; Wang,Zhehai

doi:10.3892/ol.2014.2610

Cutaneous metastasis from pancreatic cancer: A case report and systematic review of the literature

Authors:
- Hai‑Yan Zhou
- Xian‑Bao Wang
- Fang Gao
- Bing Bu
- Shu Zhang
- Zhehai Wang
View Affiliations

Affiliations: Department of Oncology, Shandong Cancer Hospital and Institute, Jinan, Shandong 250117, P.R. China, Department of Thoracic Surgery, Affiliated Hospital of Jining Medical University, Jining, Shandong 272205, P.R. China, Department of Oncology, Shandong Cancer Hospital and Institute, Jinan, Shandong 250117, P.R. China
Published online on: October 10, 2014 https://doi.org/10.3892/ol.2014.2610
Pages: 2654-2660

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Cutaneous metastasis from pancreatic cancer is uncommon, therefore, the outcome of this progression has rarely been investigated. The aim of the present report was to evaluate the clinical characteristics of patients exhibiting cutaneous metastasis from pancreatic cancer. Thus, the current report presents a rare case of cutaneous metastatic disease from pancreatic cancer and describes a systematic review of the literature. A total of 54 articles comprising 63 cases were included for analysis. The relevant clinical and pathological characteristics, as well as the treatment strategies and survival outcomes of this rare disease presentation were reviewed. The average patient was was aged 63.9 years and males constituted a marginally greater proportion of the cohort (61.9%). The predominant manifestation of the cutaneous metastasis was a nodule or mass (73%) and the most common site of the skin lesion was non‑umbilicus rather than umbilicus. The majority (66.7%) of the skin lesions were singular, particularly in patients exhibiting Sister Mary Joseph's nodule (90%). A wide range of histological subtypes presented, with a predominance of adenocarcinoma (84.1%). Of the cases that specified the tumor differentiation grade, 78.2% were moderately or poorly differentiated. Immunohistochemistry revealed that cytokeratin (CK)20‑negative, and CK7‑, CK19‑ and carbohydrate antigen (CA)19‑9‑positive were specific diagnostic markers for pancreatic cancer. Distal metastases, excluding the skin, were observed in 68.3% of patients and the median survival period was 5 months. Treatment strategies including surgery, radiation, chemotherapy or a combination improved survival time from 3.0 to 8.3 months. Cutaneous metastasis from pancreatic cancer is a rare finding, often providing the only external indication of an internal malignancy and, therefore, should be considered in the differential diagnosis of skin lesions. Metastasis to the skin indicates a widespread, general dissemination and a poor prognosis. A combination of surgery, radiotherapy and chemotherapy appears to result in improved survival rates.

View Figures

View References

1	Cascinu S, Falconi M, Valentini V and Jelic S; ESMO Guidelines Working Group. Pancreatic cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 21(Suppl 5): v55–v58. 2010.
2	Satoh K and Shimosegawa T: Pancreatic tumor: progress in diagnosis and treatment. Topics: 1. Pancreatic carcinoma: 2. Pathogenesis and pathobiology in pancreatic cancer. - The molecular mechanisms of carcinogenesis, and invasion and metastasis in pancreatic cancer. Nihon Naika Gakkai Zasshi. 101:7–16. 2012.(In Japanese).
3	Targarona Soler EM and Trias Folch M: Sister Mary Joseph’s nodule. Med Clin (Barc). 113:118–119. 1999.(In Spanish).
4	Kaoutzanis C, Chang MC, Abdul Khalek FJ and Kreske E: Non-umbilical cutaneous metastasis of a pancreatic adenocarcinoma. BMJ Case Rep. 2013.bcr2012007931. 2013.
5	Takemura N, Fujii N and Tanaka T: Cutaneous metastasis as the first clinical manifestation of pancreatic adenocarcinoma: a case treated with gemcitabine. J Dermatol. 34:662–664. 2007.
6	Khorana AA: Cancer-associated thrombosis: updates and controversies. Hematology Am Soc Hematol Educ Program. 2012:626–30. 2012.
7	Klöppel G, Rindi G, Perren A, Komminoth P and Klimstra DS: The ENETS and AJCC/UICC TNM classifications of the neuroendocrine tumors of the gastrointestinal tract and the pancreas: a statement. Virchows Arch. 456:595–597. 2012.
8	Ahmed K, Sussman JJ, Wang J and Schmulewitz N: A case of EUS-guided FNA-related pancreatic cancer metastasis to the stomach. Gastrointest Endosc. 74:231–233. 2011.
9	Lookingbill DP, Spangler N and Helm KF: Cutaneous metastases in patients with metastatic carcinoma: a retrospective study of 4020 patients. J Am Acad Dermatol. 29:228–236. 1993.
10	Cubilla A and Fitzgerald PJ: Pancreas cancer. I Duct adenocarcinoma A clinical-pathologic study of 380 patients. Pathol Annu. 13:241–289. 1978.
11	Yendluri V, Centeno B and Springett GM: Pancreatic cancer presenting as a Sister Mary Joseph’s nodule: case report and update of the literature. Pancreas. 34:161–164. 2007.
12	Horino K, Hiraoka T, Kanemitsu K, Tsuji T, Inoue K, Tanabe D, et al: Subcutaneous metastases after curative resection for pancreatic carcinoma: a case report and review of the literature. Pancreas. 19:406–408. 1999.
13	Miyahara M, Hamanaka Y, Kawabata A, Sato Y, Tanaka A, Yamamoto A, et al: Cutaneous metastasis from pancreatic cancer. Int J Pancreatol. 20:127–130. 1996.
14	Abdel-Hafez HZ: Cutaneous pancreatic metastasis: a case report and review of literature. Dermatol Surg. 34:1580–1583. 2008.
15	Bordel Gómez MT and Used Aznar MM: Cutaneous metastases from adenocarcinoma of unknown primary site. Actas Dermosifiliogr. 97:662–665. 2006.(In Spanish).
16	Takeuchi H, Kawano T, Toda T, Minamisono Y, Nagasaki S, Yao T and Sugimachi K: Cutaneous metastasis from pancreatic adenocarcinoma: a case report and a review of the literature. Hepatogastroenterology. 50:275–277. 2003.
17	Fiori E, Galati G, Bononi M, De Cesare A, Binda B, Ciardi A, Volpino P, Cangemi V and Izzo L: Subcutaneous metastasis of pancreatic cancer in the site of percutaneous biliary drainage. J Exp Clin Cancer Res. 22:151–154. 2003.
18	Bonenti G, Zanon E and Righi D: The cutaneous metastasis of a pancreatic carcinoma in a patient with biliary drainage: a case. Radiol Med. 94:264–266. 1997.(In Italian).
19	Pontinen T, Melin A, Varadi G, Khanmoradi K, Chewaproug D, Kung SC, Zaki R and Ortiz J: Cutaneous metastasis of pancreatic adenocarcinoma after kidney transplant: a case report and review of the literature. Exp Clin Transplant. 8:273–276. 2010.
20	Siriwardena A and Samarji WN: Cutaneous tumour seeding from a previously undiagnosed pancreatic carcinoma after laparoscopic cholecystectomy. Ann R Coll Surg Engl. 75:199–200. 1993.
21	Bergenfeldt M, Genell S, Lindholm K, Ekberg O and Aspelin P: Needle-tract seeding after percutaneous fine-needle biopsy of pancreatic carcinoma. Case Report Acta Chir Scand. 154:77–79. 1988.
22	Habscheid W and Kirchner T: Skin metastases following ultrasound-guided fine-needle puncture of pancreatic cancer. Dtsch Med Wochenschr. 112:283–284. 1987.(In German).
23	Akkooi AC, Dokter J and Boxma H: Unusual first presentation of metastatic pancreatic cancer as skin metastases in a burn patient. Burns. 36:e111–e114. 2010.
24	Hafez H: Cutaneous pancreatic metastasis: a case report and review of literature. Indian J Cancer. 44:111–114. 2007.
25	Pinho AV, Rooman I and Real FX: p53-dependent regulation of growth, epithelial-mesenchymal transition and stemness in normal pancreatic epithelial cells. Cell Cycle. 10:1312–1321. 2011.
26	Matros E, Bailey G, Clancy T, et al: Cytokeratin 20 expression identifies a subtype of pancreatic adenocarcinoma with decreased overall survival. Cancer. 106:693–702. 2006.
27	Gui JC, Yan WL and Liu XD: CA19-9 and CA242 as tumor markers for the diagnosis of pancreatic cancer: a meta-analysis. Clin Exp Med. 14:225–233. 2014.
28	Wang Z and Ma Q: Beta-catenin is a promising key factor in the SDF-1/CXCR4 axis on metastasis of pancreatic cancer. Med Hypotheses. 69:816–820. 2007.
29	Lookingbill DP, Spangler N and Sexton FM: Skin involvement as the presenting sign of internal carcinoma. A retrospective study of 7316 cancer patients. J Am Acad Dermatol. 22:19–26. 1990.
30	Guo JC, Li J, Hu Y, Zhang TP, Liao Q, Dai MH and Zhao YP: The role of perioperative enteral and parenteral nutrition treatment inpancreatic cancer: a multicenter, prospective randomized controlled trial. Zhonghua Wai Ke Za Zhi. 51:987–990. 2013.(In Chinese).